 |
|
| Blog results | Results 1 - 10 of about 1,179 for tracleer pulmonary hypertension. (0.28 seconds) |
| Sorted by relevance Sort by date |
| 23 Nov 2009 by Harold Sapp tracleer pulmonary hypertension revatio cause hypertension pulmonary secondary rainbow babies pediatric pulmonary hypertension pulmonary hypertension and transposition and emboli information on secondary pulmonary hypertension ... Reis en backpackers forum - http://www.backpack.nu/reisforums/ |
| 31 Aug 2009 Dr Lutz Beckert, a PAH expert in Christchurch, says that Pharmac's funding will make a difference as it will allow patients and physicians to access Tracleer as a new and important medication to treat pulmonary hypertension. ... NZDoctor RSS News Feed - http://www.nzdoctor.co.nz/ |
| 11 Aug 2009 Tracleer (bosentan) is used to treat pulmonary arterial hypertension. Includes Tracleer side effects, interactions and indications. Drugs.com - New Drug Approvals - http://www.drugs.com/newdrugs.html |
| 22 Sep 2009 Tracleer(R) has been available to Canadians since 2001, and was previously approved for the treatment of pulmonary arterial hypertension in patients with WHO Functional Class III and IV primary pulmonary hypertension, or pulmonary ... HOTEL - http://www.all-hotels.uni.cc/ |
| 1 hour ago Seek emergency medical Viagra for manPre, Blackberry, Windows Mobile sildenafil trials in pulmonary hypertensiona dose of Revatio, lisinopril Viagra135000 page views were Levitra attorneysTagamet HB); * conivaptan erectyle dysfunction ..... way to get Viagra nowmedications: * bosentan (Tracleer); cheap Cialis softtabsor heart rhythm problems; Viagra hotlinepenis (such as Peyronie's buy Viagra online discountof HIV, your doctor Viagra prescription onlinepain, nausea, ... NAM NEWS NETWORK - http://www.namnewsnetwork.org/ [ More results from NAM NEWS NETWORK ] |
| 22 Sep 2009 by Mary ... previously authorised for the communication of pulmonary arterial hypertension in patients with WHO Functional Class III and IV primary pulmonary hypertension, or pulmonary hypertension secondary to scleroderma or congenital heart ... pulmonary heart disease - http://pulmonaryheartsdisease.blogspot.com/ |
| 20 Nov 2009 Tracleer approved for mildly symptomatic WHO Functional Class II pulmonary arterial hypertension (PAH). August 11, 2009. The FDA has approved Tracleer (bosentan tablets, from Actelion), a dual endothelin receptor antagonist, ... Latest articles from MPR - http://www.empr.com/ [ More results from Latest articles from MPR ] |
| 23 Nov 2009 by Jim Edwards Actelion has received authorisation from the US FDA to extend the label of its oral pulmonary arterial hypertension (PAH) drug, Tracleer (bosentan), to include patients with mild forms of the disease, classified as WHO functional class ... Pharma Analysis RSS | BNET Industries - http://industry.bnet.com/pharma/blog/feed/rss/ |
| 1 Dec 2009 by Nik Drug: Tracleer (BOSENTAN) Sponsor: Actilion Pharmaceuticals Pty Ltd Date of designation: 4 October 2005. Indication: for the treatment of Primary Pulmonary Arterial Hypertension (WHO Class PH I) in patients with WHO Functional Class III ... Pharmainfo.net - http://www.pharmainfo.net/ |
| 15 Nov 2009 by grahamdom The inhaled needing tracleer pulmonary hypertension revatio lawsuit arrhythmias from n-desmethylation of sildenafil, and is itself corporate metabolized. The revatio headache last how long of these differences to the routine, ... EJSChart - http://www.ejschart.com/forums/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
